SCHEMBL10041206

SCHEMBL10041206

Bc1ccc(Cl)c(Cc2ccc(O)c(F)c2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.44
HSD17B10 Q99714 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
MAPT P10636 2/20 0.41
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP17A1 P05093 1/20 0.37
CYP19A1 P11511 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
MET P08581 2/20 0.36
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
SNCA P37840 1/20 0.35
IGFBP5 P24593 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29817116 0.82 CYP3A4 (0.44) CYP3A4HSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL14954622 0.82 CYP3A4 (0.44) CYP3A4HSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL10040921 0.79 MEN1 (0.46) CYP3A4HSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL10041045 0.78 CYP3A4 (0.41) CYP3A4HSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL10041207 0.76 SLC5A2 (0.50)
SCHEMBL6249245 0.75 CYP3A4 (0.57) CYP3A4HSD17B10CYP1A2CYP2D6CYP2C9
SCHEMBL30058625 0.74 CA1 (0.61) CYP3A4HSD17B10CYP2D6MAPTMEN1
SCHEMBL545298 0.74 CA1 (0.61) CYP3A4HSD17B10CYP2D6MAPTMEN1
SCHEMBL13979827 0.72 SLC5A2 (0.47) SLC6A2SLC6A4SLC6A3
SCHEMBL5071987 0.72 CYP17A1 (0.59) CYP3A4HSD17B10CYP2D6MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019496-A1 C-ARYL GLUCOSIDE DERIVATIVES, PREPARATION RPOCESS AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 WO disclosed